114) , that may (1) affect risk for colorectal cancer and (2) be modifiable by anti-proli |
115) 31 atomic bomb survivors with esophageal cancer and 96 controls (also with cancer b |
116) He had a history of colon cancer and a family history satisfying the |
117) wo cases [a patient with bilateral breast cancer and a severely obese patient (BMI |
118) strategies to defend against worry about cancer and anticipated prostatectomy-relat |
119) uring development and disease states like cancer and cardiovascular diseases. |
120) iagnostic pathways for patients with lung cancer and explore the feasibility of a me |
121) e RAS is involved in several hallmarks of cancer and how this could open a window to |
122) n highly distressing symptoms in advanced cancer and in hospice and palliative medic |
123) Ten studies on bladder cancer and ingested arsenic exposure and f |
124) f these enzymes is frequently observed in cancer and is related to aggressiveness, h |
125) The absolute risk of bladder cancer and lung cancer from ingested arsen |
126) ated in 34 immunosuppressed patients with cancer and may have favorably influenced o |
127) ffold could be used in such conditions as cancer and neurogenic urinary bladder. |
128) ere no metastatic lesions from the breast cancer and no osteoblasts or osteoclasts w |
129) isoform 2 (PKM2) can be detected in both cancer and normal cells, disagreeing with |
130) exacerbate respiratory diseases or cause cancer and organ damage. |
131) atous polyps as precursors for colorectal cancer and polypectomy. |
132) betel quid containing no tobacco and oral cancer and precancer, with implications fo |
133) factor influencing the incidences of oral cancer and precancer. |
134) ight be an important risk factor for oral cancer and precancer. |
135) gnificant concerns about risk factors for cancer and provide sound evidence about pu |
136) lly the most prevalent type of esophageal cancer and ranked as the sixth leading cau |
137) r Japanese patients with bilateral breast cancer and severely obese Japanese patient |
138) While cancer and stem cells are very different, |
139) ion and health promotion research on skin cancer and tanning to examine the outcomes |
140) ays a role in the pathogenesis of ovarian cancer and that the analysis of the methyl |
141) r of tumor-stromal interaction in ovarian cancer and the value of targeting c-MET fo |
142) ce of medical conditions in patients with cancer and their impact on outcome. |
143) age, HIV, chronic kidney disease, stroke, cancer, and chronic liver disease and cirr |
144) able in the measurement of QOL for breast cancer, and the interrelationships between |
145) SLT was harmful and causes heart disease, cancer, and tuberculosis. |
146) The importance of cancer- and other disease registries for p |
|